Improving and protecting people's lives
We drive the sustainability of the planet
Strengthening and advancing the ecosystem
Increasing the public value of biotechnology
Genomics is positioning itself as a key tool for cancer diagnosis and treatment
AseBio and Illumina have brought together legislators, clinicians, researchers and biotech companies at the Carlos III...
Biotechnology also looks after your skin
Having just returned from the summer break, and consequently from exposing our bodies to the sun, we talked to two...
AseBio joins the ShapingBio project to accelerate innovation in Europe's bioeconomy
The initiative, which includes entities from a dozen countries, aims to find responses to European climate priorities...
#NewMemberAseBio | "AseBio is the door to the networking with key relevant stakeholders in...
Meet MIMARK Diagnostics, S.L., our new member. We talked to Marina Rigau, CEO and founder of the company.
Sesión sobre «Buenas prácticas de la aplicación de la Inteligencia Artificial en salud»
El Instituto de Ingeniería del Conocimiento lanza una sesión sobre Inteligencia Artificial en salud, con el fin de...
Laminar Pharma obtains FDA Fast Track designation for LAM561 for the treatment of glioblas...
Laminar Pharma has been granted by the US FDA with a Fast-Track designation for the investigation of LAM561 for the...
ALGABELLUM, el proyecto CDTI de Biorizon Biotech que aprovecha integralmente el alga para ...
Finaliza con excelentes resultados el proyecto de I+D ALGABELLUM, financiado por CDTI
The biotech sector is global and internationalization a key axis of the development of its companies. AseBio promotes major events, such as BioSpain, and since 2008 manages the 'ICEX Internationalization Plan for biotechnology companies'. Discover what we can offer you.
